SCHEMBL1958671

SCHEMBL1958671

O=Cc1cc(O)ccc1Br.O=Cc1ccccc1-c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.40
PTGS1 P23219 1/20 0.40
CYP26A1 O43174 2/20 0.39
ERN1 O75460 4/20 0.39
XDH P47989 2/20 0.38
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
MIF P14174 1/20 0.37
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
ABL1 P00519 1/20 0.35
ABCB1 P08183 1/20 0.35
BCR P11274 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2480246 0.90 XDH (0.43) CYP26A1ERN1XDHCA12CA9
SCHEMBL1958177 0.81 XDH (0.49) ERN1XDHCA12CA9MIF
SCHEMBL387189 0.81 XDH (0.51) PTGS2PTGS1ERN1XDHMEN1
SCHEMBL1957905 0.80 PTGS2 (0.42) PTGS2PTGS1ERN1XDHCA12
SCHEMBL6001180 0.78 PELI1 (0.47) ERN1XDHCA12CA9MIF
SCHEMBL5013561 0.77 XDH (0.51) ERN1XDHMEN1LMNAKMT2A
SCHEMBL289452 0.77 BACE1 (0.49) ERN1CA9MEN1LMNAMAPT
SCHEMBL31302309 0.77 BACE1 (0.49) ERN1CA9MEN1LMNAMAPT
SCHEMBL29100201 0.76 TRIM24 (0.42) CYP26A1ERN1MEN1LMNAMAPT
SCHEMBL869016 0.74 ERN1 (0.47) ERN1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507229-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 EP disclosed
WO-2011068561-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 WO disclosed